middle.news
How Aroa Biosurgery’s Record Myriad Sales Signal a Breakout Year Ahead
9:07am on Thursday 16th of October, 2025 AEDT
•
Healthcare
Read Story
How Aroa Biosurgery’s Record Myriad Sales Signal a Breakout Year Ahead
9:07am on Thursday 16th of October, 2025 AEDT
Key Points
Operating cash flow of NZ$2.1 million for the quarter
Record quarterly sales of NZ$10.2 million for Myriad product family
Cash balance increased to NZ$23.4 million, remaining debt-free
FY26 revenue guidance reaffirmed at NZ$92-100 million with EBITDA of NZ$5-8 million
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
AROA BIOSURGERY (ASX:ARX)
OPEN ARTICLE